Former Edwards exec to lead emerging mitral valve repair firm NeoChord
This article was originally published in Clinica
Executive Summary
NeoChord, a specialist in minimally-invasive repair of mitral valve prolapse, has appointed former Edwards Lifesciences senior executive David Chung president and CEO. Mr Chung replaces John Seaberg, who has resigned after seven years at the helm of the Eden Prarie, Minnesota firm.